Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcimimetics versus oral paricalcitol in renal transplant patients with persistent secondary hyperparathyroidism
2010-021041-42Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Oct 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of paricalcitol and cinacalcet in secondary hyperparathyroidism (SHPT) and hypercalcemia (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Started Oct 2010; status: active.
02
Drugs
paricalcitolcinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)hypercalcemia
Beyond the preview
Go deeper on 2010-021041-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021041-42.